DENV-IN-2
DENV-IN-2 is a potent dengue viral replication inhibitor extracted from patent WO2018215315A1, compound 6AB, has an EC50 of 0.016 nM. DENV-IN-2 shows high potent activity against all four serotypes of the Dengue virus with EC50s ranging from 0.013 to 0.029 nM[1].
Product Specifications
CAS Number
2253675-62-4
UNSPSC
12352005
Target
Dengue Virus; DNA/RNA Synthesis; Flavivirus
Type
Reference compound
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/denv-in-2.html
Solubility
10 mM in DMSO
Smiles
O=C([C@H]1[C@H](COC2=CC(OC)=CC(N[C@@H](C3=CC=C(Cl)C=C3)C(N4CCC5=C4C=C(OC(F)(F)F)C=C5)=O)=C2)C1)O
Molecular Formula
C29H26ClF3N2O6
Molecular Weight
590.97
References & Citations
[1]Jean-François BONFANTI, et al.Substituted indoline derivatives as dengue viral replication inhibitors. WO2018215315A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
ARP2 Polyclonal Antibody, AbBy Fluor™ 350 Conjugated
ARP2 Polyclonal Antibody, AbBy Fluor™ 350 Conjugated
TMPRSS15 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)